Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 495 participants.

Also called NCT01729559

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 495 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01729559
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01729559. Randomized; single masking; primary purpose prevention. Start 2012-11 (registry gives no type); primary completion 2014-09 (actual). Results posted on 2016-07-18.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin
Condition
Venous Thromboembolic Disease
Intervention (Drug)
5000 Units unfractionated Heparin Q 8 hr
Intervention (Drug)
30mg enoxaparin Q12 hr
Lead sponsor
Scripps Health (class: other)

Record details

Record id
cardio:ct-nct01729559
Content hash
856d9686db33c4e7ed7d5667128a4cd230bdf6f04da63fe732c50cda6e98bf25